Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Imaging
Search: search_blue_button Advanced Search
Published Online
on May 13, 2009

Circulation: Cardiovascular Imaging. 2009
Published online before print May 13, 2009, doi: 10.1161/CIRCIMAGING.108.846865
A more recent version of this article appeared on July 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/4/331    most recent
CIRCIMAGING.108.846865v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laitinen, I.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laitinen, I.
Right arrow Articles by Schwaiger, M.
Related Collections
Right arrow Imaging

Original Article

Evaluation of {alpha}vβ3 Integrin -targeted PET Tracer 18F–Galacto–RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice

Iina Laitinen1,5; Antti Saraste2; Eliane Weidl2; Thorsten Poethko2; Axel W. Weber2; Stephan G. Nekolla2; Pia Leppänen3; Seppo Ylä–Herttuala3; Gabriele Hölzlwimmer4; Axel Walch4; Irene Esposito4; Hans–Jürgen Wester2; Juhani Knuuti1 and Markus Schwaiger2

1 University of Turku, Turku, Finland;
2 Technische Universität München, München, Germany;
3 University of Kuopio, Kuopio, Finland;
4 Helmholtz Zentrum München, München/Neuherberg, Germany

5 E-mail: iina.laitinen{at}tyks.fi

Background18F–Galacto–RGD is a positron emission tomography (PET) tracer binding to {alpha}vβ3 integrin that is expressed by macrophages and endothelial cells in atherosclerotic lesions. Therefore, we evaluated 18F–galacto–RGD for imaging vascular inflammation by studying its uptake into atherosclerotic lesions of hypercholesterolemic mice in comparison to deoxyglucose.

Methods and Results—Hypercholesterolemic LDLR-/-ApoB100/100 mice on western diet and normally fed adult C57BL/6 control mice were injected with 18F–galacto–RGD and 3H–deoxyglucose followed by imaging with a small animal PET/CT scanner. The aorta was dissected 2 hours after tracer injection for biodistribution studies, autoradiography and histology. Biodistribution of 18F–galacto–RGD was higher in the atherosclerotic than in the normal aorta. Autoradiography demonstrated focal 18F–galacto–RGD uptake in the atherosclerotic plaques when compared to the adjacent, normal vessel wall or adventitia. Plaque-to-normal vessel wall ratios were comparable to those of deoxyglucose. While angiogenesis was not detected, 18F–galacto–RGD uptake was associated with macrophage density and deoxyglucose accumulation in the plaques. Binding to atherosclerotic lesions was efficiently blocked in competition experiments. In vivo imaging visualized 18F-galacto-RGD uptake co-localizing with calcified lesions of the aortic arch as seen in CT angiography.

Conclusions18F–Galacto–RGD demonstrates specific uptake in atherosclerotic lesions of mouse aorta. In this model, its uptake was associated with macrophage density. 18F–Galacto–RGD is a potential tracer for non-invasive imaging of inflammation in atherosclerotic lesions.

Key Words: atherosclerosis • imaging • inflammation • plaque • radioisotopes